Form C/A - Offering Statement: [Amend]
SEC Accession No. 0002008980-24-000002
Filing Date
2024-05-02
Accepted
2024-05-02 12:29:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 8799
2 FORM CA formca.pdf EX-99 7066517
  Complete submission text file 0002008980-24-000002.txt   9732294
Mailing Address 651, NORTH BROAD STREET, SUITE 201, MIDDLETOWN DE 19709
Business Address 651, NORTH BROAD STREET, SUITE 201, MIDDLETOWN DE 19709 (302) 451-9161
Rejuvine Life Sciences Inc (Filer) CIK: 0002008980 (see all company filings)

EIN.: 612079105 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C/A | Act: 33 | File No.: 020-33995 | Film No.: 24906649